소장자료
| LDR | 05326cam a2200745 i 4500 | ||
| 001 | 0100776719▲ | ||
| 003 | OCoLC▲ | ||
| 005 | 20231018174101▲ | ||
| 006 | m d ▲ | ||
| 007 | cr cn|||||||||▲ | ||
| 008 | 220302s2022 dcua ob 000 0 eng ▲ | ||
| 010 | ▼a 2021949602▲ | ||
| 016 | 7 | ▼a9918366141406676▼2DNLM▲ | |
| 019 | ▼a1295212304▼a1295214934▼a1295243851▲ | ||
| 020 | ▼a0309269474▲ | ||
| 020 | ▼a9780309269476▼q(electronic bk.)▲ | ||
| 020 | ▼z9780309269452▲ | ||
| 020 | ▼z0309269458▲ | ||
| 035 | ▼a3165662▼b(N$T)▲ | ||
| 035 | ▼a(OCoLC)1296428759▼z(OCoLC)1295212304▼z(OCoLC)1295214934▼z(OCoLC)1295243851▲ | ||
| 040 | ▼aNLM▼beng▼erda▼cNLM▼dYDX▼dEBLCP▼dOCLCO▼dOCLCF▼dN$T▲ | ||
| 042 | ▼apcc▲ | ||
| 049 | ▼aMAIN▲ | ||
| 050 | 4 | ▼aQR177▲ | |
| 060 | 0 | 0 | ▼aQW 45▲ |
| 082 | 0 | 4 | ▼a616.9041▼223/eng/20230106▲ |
| 245 | 0 | 0 | ▼aCombating antimicrobial resistance and protecting the miracle of modern medicine▼h[electronic resource] /▼cGuy H. Palmer, Gillian J. Buckley, editors ; Committee on the Long-Term Health and Economic Effects of Antimicrobial Resistance in the United States, Board on Population Health and Public Health Practice, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine.▲ |
| 264 | 1 | ▼aWashington, DC :▼bNational Academies Press,▼c[2022]▲ | |
| 300 | ▼a1 online resource (1 PDF file (xxviii, 365 pages)) :▼billustrations.▲ | ||
| 336 | ▼atext▼btxt▼2rdacontent▲ | ||
| 337 | ▼acomputer▼bc▼2rdamedia▲ | ||
| 338 | ▼aonline resource▼bcr▼2rdacarrier▲ | ||
| 490 | 1 | ▼aConsensus study report of the National Academies of Sciences, Engineering, Medicine▲ | |
| 504 | ▼aIncludes bibliographical references.▲ | ||
| 505 | 0 | ▼aIntro -- FrontMatter -- Reviewers -- Preface -- Acknowledgments -- Contents -- Boxes, Figures, and Tables -- Acronyms and Abbreviations -- Summary -- 1 Introduction -- 2 The Scope of the Problem -- 3 The Health and Economic Burden of Resistance -- 4 Strengthening Surveillance -- 5 Stewardship and Infection Prevention -- 6 Bringing New Products to Market and Ensuring Their Reach -- 7 The National Action Plan for Combating Antibiotic-Resistant Bacteria -- 8 A Role for the United States in Coordinated Global Action -- Appendix A: Committee Member Biographies▲ | |
| 505 | 8 | ▼aAppendix B: Disclosure of Unavoidable Conflict of Interest -- Appendix C: Open Session Agendas▲ | |
| 520 | 3 | ▼aAntimicrobial resistance is a health problem that threatens to undermine almost a century of medical progress. Moreover, it is a global problem that requires action both in the United States and internationally. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine discusses ways to improve detection of resistant infections in the United States and abroad, including monitoring environmental reservoirs of resistance. This report sets out a strategy for improving stewardship and preventing infections in humans and animals. The report also discusses the strength of the pipeline for new antimicrobial medicines and steps that could be taken to bring a range of preventive and therapeutic products for humans and animals to the market.▲ | |
| 536 | ▼aThis project has been funded in whole or in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN263201800029I, Task Order No. 75N98020F00003. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.▲ | ||
| 588 | ▼aDescription based on online resource; title from PDF title page (viewed April 20, 2022).▲ | ||
| 590 | ▼aWorldCat record variable field(s) change: 050, 082▲ | ||
| 650 | 0 | ▼aDrug resistance in microorganisms.▲ | |
| 650 | 0 | ▼aAnti-infective agents.▲ | |
| 650 | 0 | ▼aEnvironmental monitoring.▲ | |
| 650 | 1 | 2 | ▼aDrug Resistance, Microbial▲ |
| 650 | 1 | 2 | ▼aDrug Resistance, Bacterial▲ |
| 650 | 2 | 2 | ▼aAnti-Infective Agents▲ |
| 650 | 2 | 2 | ▼aAnti-Bacterial Agents▲ |
| 650 | 2 | 2 | ▼aAntimicrobial Stewardship▲ |
| 650 | 2 | 2 | ▼aEnvironmental Monitoring▲ |
| 650 | 6 | ▼aMicro-organismes▼xRésistance aux médicaments.▲ | |
| 650 | 6 | ▼aBactéries pathogènes▼xRésistance aux médicaments.▲ | |
| 650 | 6 | ▼aAntiinfectieux.▲ | |
| 650 | 6 | ▼aEnvironnement▼xSurveillance.▲ | |
| 650 | 7 | ▼aAnti-infective agents.▼2fast▼0(OCoLC)fst00810345▲ | |
| 650 | 7 | ▼aDrug resistance in microorganisms.▼2fast▼0(OCoLC)fst00898704▲ | |
| 650 | 7 | ▼aEnvironmental monitoring.▼2fast▼0(OCoLC)fst00913214▲ | |
| 651 | 2 | ▼aUnited States▲ | |
| 700 | 1 | ▼aBuckley, Gillian J.,▼eeditor.▲ | |
| 700 | 1 | ▼aPalmer, Guy▼q(Guy Hughes),▼d1955-▼eeditor.▲ | |
| 710 | 2 | ▼aNational Academies of Sciences, Engineering, and Medicine (U.S.).▼bCommittee on the Long-Term Health and Economic Effects of Antimicrobial Resistance in the United States,▼eissuing body.▲ | |
| 776 | 0 | 8 | ▼iPrint version:▼aNational Academies of Sciences, Engineering, and Medicine▼tCombating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine▼dWashington, D.C. : National Academies Press,c2022▼z9780309269452▲ |
| 830 | 0 | ▼aConsensus study report.▲ | |
| 856 | 4 | 0 | ▼3EBSCOhost▼uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3165662▲ |
Combating antimicrobial resistance and protecting the miracle of modern medicine[electronic resource]
자료유형
국외eBook
서명/책임사항
Combating antimicrobial resistance and protecting the miracle of modern medicine [electronic resource] / Guy H. Palmer, Gillian J. Buckley, editors ; Committee on the Long-Term Health and Economic Effects of Antimicrobial Resistance in the United States, Board on Population Health and Public Health Practice, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine.
개인저자
단체저자
형태사항
1 online resource (1 PDF file (xxviii, 365 pages)) : illustrations.
총서사항
서지주기
Includes bibliographical references.
내용주기
Intro -- FrontMatter -- Reviewers -- Preface -- Acknowledgments -- Contents -- Boxes, Figures, and Tables -- Acronyms and Abbreviations -- Summary -- 1 Introduction -- 2 The Scope of the Problem -- 3 The Health and Economic Burden of Resistance -- 4 Strengthening Surveillance -- 5 Stewardship and Infection Prevention -- 6 Bringing New Products to Market and Ensuring Their Reach -- 7 The National Action Plan for Combating Antibiotic-Resistant Bacteria -- 8 A Role for the United States in Coordinated Global Action -- Appendix A: Committee Member Biographies
Appendix B: Disclosure of Unavoidable Conflict of Interest -- Appendix C: Open Session Agendas
Appendix B: Disclosure of Unavoidable Conflict of Interest -- Appendix C: Open Session Agendas
요약주기
Antimicrobial resistance is a health problem that threatens to undermine almost a century of medical progress. Moreover, it is a global problem that requires action both in the United States and internationally. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine discusses ways to improve detection of resistant infections in the United States and abroad, including monitoring environmental reservoirs of resistance. This report sets out a strategy for improving stewardship and preventing infections in humans and animals. The report also discusses the strength of the pipeline for new antimicrobial medicines and steps that could be taken to bring a range of preventive and therapeutic products for humans and animals to the market.
주제
Drug resistance in microorganisms.
Anti-infective agents.
Environmental monitoring.
Drug Resistance, Microbial
Drug Resistance, Bacterial
Anti-Infective Agents
Anti-Bacterial Agents
Antimicrobial Stewardship
Environmental Monitoring
Micro-organismes, Résistance aux médicaments.
Bactéries pathogènes, Résistance aux médicaments.
Antiinfectieux.
Environnement, Surveillance.
Anti-infective agents.
Drug resistance in microorganisms.
Environmental monitoring.
United States
Anti-infective agents.
Environmental monitoring.
Drug Resistance, Microbial
Drug Resistance, Bacterial
Anti-Infective Agents
Anti-Bacterial Agents
Antimicrobial Stewardship
Environmental Monitoring
Micro-organismes, Résistance aux médicaments.
Bactéries pathogènes, Résistance aux médicaments.
Antiinfectieux.
Environnement, Surveillance.
Anti-infective agents.
Drug resistance in microorganisms.
Environmental monitoring.
United States
기타형태저록
ISBN
0309269474 9780309269476
관련 인기대출 도서